Naltrexone 380 MG

DRUG2 trials

Sponsors

Denver Health and Hospital Authority, Go Medical Industries Pty Ltd

Conditions

Alcohol Use Disorder, SevereOpioid-use Disorder

Early Phase 1

Inpatient Single Dose Interventions for Alcohol Use Disorder

CompletedNCT04562779

Denver Health and Hospital AuthorityAlcohol Use Disorder, Severe

Start: 2021-01-19End: 2022-02-01Updated: 2024-05-02

Phase 1

Pharmacokinetic Study of Vivitrol in Healthy Participants

CompletedNCT04716881

Go Medical Industries Pty LtdOpioid-use Disorder

Start: 2021-01-25End: 2022-04-04Updated: 2024-02-23

Related Papers

Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates

Addiction Science & Clinical Practice2022-11-2221 citations